These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29283786)

  • 21. Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis.
    White EM; Macy JI; Bateman KM; Comstock TL
    Curr Med Res Opin; 2008 Jan; 24(1):287-96. PubMed ID: 18062846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis.
    Asbell P; Howes J
    CLAO J; 1997 Jan; 23(1):31-6. PubMed ID: 9001768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.
    Dell SJ; Shulman DG; Lowry GM; Howes J
    Am J Ophthalmol; 1997 Jun; 123(6):791-7. PubMed ID: 9535623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.
    Oner V; Türkcü FM; Taş M; Alakuş MF; Işcan Y
    Jpn J Ophthalmol; 2012 Jul; 56(4):312-8. PubMed ID: 22622345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Loteprednol 0.5% and Fluorometholone 0.1% After Strabismus Surgery in Children.
    Yoo YJ; Yang HK; Hwang JM
    J Ocul Pharmacol Ther; 2018; 34(6):468-476. PubMed ID: 29958057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraocular pressure response to loteprednol etabonate in known steroid responders.
    Bartlett JD; Horwitz B; Laibovitz R; Howes JF
    J Ocul Pharmacol; 1993; 9(2):157-65. PubMed ID: 8345288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
    Rajpal RK; Digby D; D'Aversa G; Mah F; Hollander DA; Conway T
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):305-8. PubMed ID: 21574815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loteprednol Etabonate for the Treatment of Dry Eye Disease.
    Beckman K; Katz J; Majmudar P; Rostov A
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):497-511. PubMed ID: 32391735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
    Holland EJ; Bartlett JD; Paterno MR; Usner DW; Comstock TL
    Cornea; 2008 Jan; 27(1):50-5. PubMed ID: 18245967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model.
    Berdy GJ; Stoppel JO; Epstein AB
    Clin Ther; 2002 Jun; 24(6):918-29. PubMed ID: 12117082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
    Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K
    Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis.
    Dell SJ; Lowry GM; Northcutt JA; Howes J; Novack GD; Hart K
    J Allergy Clin Immunol; 1998 Aug; 102(2):251-5. PubMed ID: 9723669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
    Vittitow JL; Williams JI
    J Cataract Refract Surg; 2020 Aug; 46(8):1092-1101. PubMed ID: 32352250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain.
    Salinger CL; Gaynes BI; Rajpal RK
    Am J Manag Care; 2019 Jul; 25(12 Suppl):S215-S226. PubMed ID: 31419092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis.
    Wu LQ; Chen X; Lou H; Cheng JW; Wei RL
    Curr Med Res Opin; 2015 Aug; 31(8):1509-18. PubMed ID: 26039179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.
    Chen M; Gong L; Sun X; Gu Y; He X; Qu J; Wang L; Zhang M; Zhong X
    Curr Med Res Opin; 2012 Mar; 28(3):385-94. PubMed ID: 22256909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid.
    Comstock TL; Sheppard JD
    Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.
    Howes JF; Baru H; Vered M; Neumann R
    J Ocul Pharmacol; 1994; 10(1):289-93. PubMed ID: 8207332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis.
    Bartlett JD; Howes JF; Ghormley NR; Amos JF; Laibovitz R; Horwitz B
    Curr Eye Res; 1993 Apr; 12(4):313-21. PubMed ID: 8319490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.